As part of its OncView™ video series, CancerNetwork® spoke with Roy Herbst, MD, PhD, chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, about currently available treatment options and strategies in immunotherapy for treating non–small cell lung cancer (NSCLC).

In the video series, Herbst discussed the following:

·      Treatment Options in Non–Small Cell Lung Cancer

·      Monitoring Response to Therapy in NSCLC

·      Role of ctDNA in Monitoring Treatment Response in NSCLC

·      Clinical Decision-Making in NSCLC

·      Recap: Monitoring With ctDNA for Immunotherapy Response in Lung Cancer

To watch more videos in CancerNetwork®’s OncView™ series, visit cancernetwork.com/oncview.

Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify or anywhere podcasts are available.